Jump Financial, LLC Cerus Corp Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$2.65 - $3.81 $166,685 - $239,649	62,900 New	62,900 $186,000
Q1 2023 May 03, 2023	BUY	$2.65 - $3.81 $166,685 - $239,649	62,900 New	62,900 $186,000
Q2 2022 Aug 09, 2022	SELL	$4.41 - $5.69 $190,953 - $246,377	-43,300 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.81 - $6.99 $148,148 - $215,292	30,800 Added 246.4%	43,300 $238,000
Q4 2021 Feb 10, 2022	SELL	$5.97 - $7.93 $111,042 - $147,498	-18,600 Reduced 59.81%	12,500 $85,000
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $148,969 - $207,748	31,100 New	31,100 $189,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $312M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.